Vuity, an eye drop for the treatment of presbyopia, is now available, according to a press release from AbbVie.
“We are pleased to be able to bring this first-of-its-kind treatment to market sooner than expected for the millions of Americans with presbyopia who may benefit from it,” Jag Dosanjh, senior vice president medical therapeutics at Allergan, an AbbVie company, said in the release.
Vuity delivers a formulation of pilocarpine to the eye to reduce pupil size, improving near and intermediate vision without sacrificing distance vision.
The FDA approved Vuity in October following